Cas12 and Cas13 Editing Platforms
CRISPR systems beyond Cas9 that expand DNA targeting, RNA targeting, diagnostics, and transcriptome engineering capabilities.
Core metadata
- ID: cas12_cas13_editing_platforms
- Era: Modern
- First known date: 2015 (decade)
- Region: Global genome-editing research
- Review status: source_checked
- Maturity: emerging
Prerequisites
- CRISPR Adaptive Immunity (crispr_adaptive_immunity)
- RNA Interference (rna_interference)
- Single-Guide RNA Design (single_guide_rna_design)
Dependents
- None.
Fields
Field lanes
- Genome Editing / CRISPR-Cas: Editing Platforms
Node sources
- Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system (Cell / Broad Institute, 2015, primary_paper) • Supports: node, maturity
- RNA targeting with CRISPR-Cas13 (Nature / Broad Institute, 2017, primary_paper) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 75%
- Prerequisite sources: 4
- expert_inference: 1
- primary_source: 2
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Single-Guide RNA Design (single_guide_rna_design) | enabling | 68% | expert_inference | Single-Guide RNA Design provides a capability that enables this technology without being the only possible path. |
|
| RNA Interference (rna_interference) | historical_predecessor | 72% | primary_source | RNA interference is a prior RNA-knockdown approach and comparison point for Cas13, not a hard prerequisite for Cas12/Cas13 platforms as a whole. |
|
| CRISPR Adaptive Immunity (crispr_adaptive_immunity) | historical_predecessor | 86% | primary_source | Cas12/Cpf1 and Cas13 are class 2 CRISPR-Cas effectors, so the shared foundation is broader CRISPR-Cas adaptive immunity rather than Cas9-specific genome editing. |
|
This page is generated from canonical era JSON and is indexable by URL.